WINDROSE HEALTH INVESTORS


Associated tags: Financial services, Windrose, Patient, Latham & Watkins, Sale, Medicine, Bank, Health

Locations: NEW YORK, UNITED STATES, NEW YORK CITY, MARYLAND, PENNSYLVANIA, TREVOSE

WindRose Portfolio Company Healthmap Raises $100 Million to Continue Fighting Kidney Disease

Retrieved on: 
Thursday, August 10, 2023

NEW YORK, Aug. 10, 2023 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), a leading healthcare-focused private equity firm, announced that its portfolio company, Healthmap Solutions, Inc. ("Healthmap"), has raised $100 million to support the ongoing expansion of its business.

Key Points: 
  • NEW YORK, Aug. 10, 2023 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), a leading healthcare-focused private equity firm, announced that its portfolio company, Healthmap Solutions, Inc. ("Healthmap"), has raised $100 million to support the ongoing expansion of its business.
  • Healthmap is a national population health management company focused on kidney disease.
  • The company has grown rapidly and is currently contracted with its health plan customers to serve over 160,000 individuals.
  • We believe that Healthmap has built a differentiated approach to managing chronic kidney disease.

WindRose Health Investors Closes Fund VI at Over $1.4 Billion

Retrieved on: 
Wednesday, July 12, 2023

NEW YORK, July 12, 2023 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), a leading healthcare-focused private equity firm, has closed its sixth fund, WindRose Health Investors VI, L.P. ("Fund VI") with over $1.4 billion in limited partner and general partner commitments.

Key Points: 
  • NEW YORK, July 12, 2023 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), a leading healthcare-focused private equity firm, has closed its sixth fund, WindRose Health Investors VI, L.P. ("Fund VI") with over $1.4 billion in limited partner and general partner commitments.
  • The fund closed at its hard cap and significantly exceeded the size of its $705 million predecessor fund.
  • "We are grateful to have earned the trust of a world-class group of investors and will work diligently on their behalf to execute our strategy," said Oliver T. Moses, WindRose Managing Partner.
  • Weil Gotshal & Manges LLP served as legal counsel in the fund formation of Fund VI.

WindRose Health Investors Adds Bank's Apothecary to Behavioral Health Pharmacy Platform; Announces Eric Elliott as Chief Executive Officer

Retrieved on: 
Thursday, November 3, 2022

Bank's, through a merger with Terrapin Pharmacy and Ganse Apothecary, significantly expands the footprint of WindRose's behavioral health pharmacy platform.

Key Points: 
  • Bank's, through a merger with Terrapin Pharmacy and Ganse Apothecary, significantly expands the footprint of WindRose's behavioral health pharmacy platform.
  • WindRose recapitalized Terrapin Pharmacy in December 2021 and Ganse Apothecary in June 2022.
  • In conjunction with the acquisition of Bank's, WindRose announced Eric Elliott as the Chief Executive Officer of the combined company.
  • WindRose Health Investors, LLC ("WindRose") makes equity investments in companies that operate within the services sectors of the healthcare industry.

WindRose Health Investors Names Operating Partner

Retrieved on: 
Tuesday, February 15, 2022

NEW YORK, Feb. 15, 2022 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that Mitchell Daitz, a highly successful healthcare CEO and entrepreneur, has joined WindRose as an Operating Partner.

Key Points: 
  • NEW YORK, Feb. 15, 2022 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that Mitchell Daitz, a highly successful healthcare CEO and entrepreneur, has joined WindRose as an Operating Partner.
  • Under Mr. Daitz's leadership as CEO (and subsequently Chairman), Vital Decisions grew rapidly and ultimately delivered a 5x investment return for WindRose.
  • WindRose's Managing Partner, Oliver T. Moses, said, "We have been fortunate to work alongside Mitchell for over a decade.
  • WindRose Health Investors, LLC ("WindRose") makes equity investments in companies that operate within the services sectors of the healthcare industry.

basys and ISSI Merge to Form the Leading Multiemployer Benefits Administration Solutions Provider

Retrieved on: 
Wednesday, January 5, 2022

BALTIMORE, Jan. 5, 2022 /PRNewswire/ -- basys and Innovative Software Solutions Inc. ("ISSI"), leading providers of specialized benefits administration solutions, today announced that they have merged to become the industry leader for innovative multiemployer benefits solutions.

Key Points: 
  • BALTIMORE, Jan. 5, 2022 /PRNewswire/ -- basys and Innovative Software Solutions Inc. ("ISSI"), leading providers of specialized benefits administration solutions, today announced that they have merged to become the industry leader for innovative multiemployer benefits solutions.
  • Together basys and ISSI will provide administrators and participants with unmatched technology, support, and expertise in all facets of multiemployer benefits administration.
  • "I am truly excited to lead such an experienced team of over 300 benefits administration professionals as we continue to serve customers with best-in-class benefits administration solutions."
  • For more on basys, visit www.basys.com/
    For nearly four decades, Innovative Software Solutions, Inc. (ISSI) has been a leading provider of benefit administration technology solutions and services.

WindRose Health Investors Completes the Sale of Vital Decisions to Evolent Health

Retrieved on: 
Wednesday, October 6, 2021

NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced today that it has completed the sale of Vital Decisions, LLC ("Vital Decisions" or the "Company") to Evolent Health, Inc. ("Evolent Health").

Key Points: 
  • NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced today that it has completed the sale of Vital Decisions, LLC ("Vital Decisions" or the "Company") to Evolent Health, Inc. ("Evolent Health").
  • Vital Decisions will report into Evolent's specialty management offering, New Century Health, and will be consolidated into Evolent's Clinical Solutions segment.
  • WindRose Health Investors, LLC ("WindRose") makes equity investments in companies that operate within the services sectors of the healthcare industry.
  • Evolent Health (NYSE: EVH) delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable.

Frazier Healthcare Partners Announces Acquisition of Accuity Delivery Systems

Retrieved on: 
Thursday, October 29, 2020

On October 26, 2020, Frazier Healthcare Partners, a Seattle-based healthcare investment firm, completed its acquisition of Accuity Delivery Systems (Accuity, or the Company), a leading provider of physician-led Revenue Integrity and Clinical Documentation Improvement (CDI) services.

Key Points: 
  • On October 26, 2020, Frazier Healthcare Partners, a Seattle-based healthcare investment firm, completed its acquisition of Accuity Delivery Systems (Accuity, or the Company), a leading provider of physician-led Revenue Integrity and Clinical Documentation Improvement (CDI) services.
  • Both Todd and Robert bring decades of relevant experience scaling healthcare services organizations and will help Accuity continue its rapid growth trajectory.
  • Jamie Wells, President of Accuity, added, This is a great opportunity for our company, and we are very excited to have Frazier Healthcare and 22C Capital as new partners.
  • Founded in 1991, Frazier Healthcare Partners is a leading middle market private equity firm focused exclusively on healthcare.

WindRose Health Investors, LLC Announces Recapitalization of basys, LLC

Retrieved on: 
Thursday, July 19, 2018

NEW YORK, July 19, 2018 /PRNewswire/ --WindRose Health Investors, LLC ("WindRose"), a healthcare-focused private equity firm, announced that funds managed by WindRose have completed a recapitalization of basys, LLC ("basys").

Key Points: 
  • NEW YORK, July 19, 2018 /PRNewswire/ --WindRose Health Investors, LLC ("WindRose"), a healthcare-focused private equity firm, announced that funds managed by WindRose have completed a recapitalization of basys, LLC ("basys").
  • WindRose Health Investors, formerly MTS Health Investors, makes equity investments in companies that operate within the services sectors of the healthcare industry.
  • WindRose Health Investors focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions.
  • WindRose Health Investors is based in New York City and invests in companies throughout the United States.